• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Backed by Redesign Health, MedArrive Launches with $4.5M in Funding for Care Management Platform

Share:

December 9, 2020

Highlights on this story:
  • With $4.5 million in funding from Kleiner Perkins and Define Ventures, and backed by Redesign Health, MedArrive is poised to bridge the virtual care gap and make affordable at-home care the new norm.
  • Co-founded by the former head of Uber Health, MedArrive enables healthcare providers to seamlessly extend care services into the home, unlocking access to high-quality healthcare for more people at a fraction of the cost.
  • MedArrive’s fully integrated care management platform allows providers and payors to bridge the virtual care gap by marrying physician-led telemedicine with hands-on care from EMS professionals.

MedArrive, a new health IT startup has emerged from stealth with the official launch of a new care management platform that enables healthcare providers and payors to extend services into the home, scaling access to high-quality healthcare and meaningfully reducing costs for providers and their patients. Co-founded by Dan Trigub (former head of Uber Health) and Inna Plumb, MedArrive bridges the virtual care gap by integrating physician-led telemedicine with hands-on care from a network of trusted EMS professionals, improving patient outcomes while empowering an underutilized segment of healthcare workers.

Backed by healthcare innovation platform and venture studio Redesign Health, MedArrive has raised $4.5 million in seed funding, co-led by Kleiner Perkins and Define Ventures. As part of the seed funding, Annie Case, Principal at Kleiner Perkins, and Lynne Chou O’Keefe, Founder and Managing Partner at Define Ventures, will both join the MedArrive Board of Directors.

In-Person, At Home, On-Demand

MedArrive taps into a capable workforce of EMS professionals (e.g., EMTs and paramedics) so they can leverage the full scope of their training, earn supplemental income, and diversify their day-to-day responsibilities. At the same time, patients using MedArrive are able to access trusted medical expertise from the safety of their homes and within their existing health systems, ultimately resulting in better patient outcomes, a better-utilized healthcare workforce, and significant cost savings for patients and providers alike.

More Than 20k Trusted EMTs & Paramedics Nationwide

Today, MedArrive partners can tap into a dense network of more than 20k trusted EMTs and paramedics ready to be deployed across the country, with equal representation in rural and urban markets. This will be particularly critical for our partners looking to distribute flu vaccines and, when available, a COVID-19 vaccine without overwhelming health systems. Additional services include chronic condition management, transitional care, readmission prevention, urgent care, palliative care, and more. MedArrive provides the most extensive coverage for providers and payors looking to expand their impact and scale care into the home to meet the diverse needs of their patients.

Expansion Plans

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

This injection of capital will enable MedArrive to continue building their innovative platform, growing their team of industry experts, and driving the expansion of key healthcare provider partnerships across the country. With an initial focus on the Florida market, the team expects to expand quickly and effectively over the coming months.

“Now more than ever, as we continue battling a global pandemic, patients deserve healthcare that is accessible, affordable, and safe,” said Dan Trigub, co-founder and CEO of MedArrive. “The current pandemic has placed additional stress on our already flawed health system – patients are avoiding clinics, delaying preventative and critical care, and facing financial strain. By working alongside communities of EMS professionals, providers, and payors to bring high quality care into the home at a fraction of the cost of alternatives, MedArrive’s integrated solution is putting patients back at the center of care.”

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • NVIDIA Develops AI Model to Accurately Predict Oxygen Needs for COVID-19 PatientsNVIDIA Develops AI Model to Accurately Predict Oxygen Needs for COVID-19 Patients
  • At Mount Sinai, monetary incentives drive medication adherenceAt Mount Sinai, monetary incentives drive medication adherence
  • Amgen to buy Copenhagen-based Nuevolution for $167 millionAmgen to buy Copenhagen-based Nuevolution for $167 million
  • Philips, Spencer Health Launches In-Home Medication Adherence & Telehealth Platform in EuropePhilips, Spencer Health Launches In-Home Medication Adherence & Telehealth Platform in Europe
  • Ophthotech Expands Innovative Retinal Disease Pipeline with Acquisition of Versant Ventures’ Inception 4Ophthotech Expands Innovative Retinal Disease Pipeline with Acquisition of Versant Ventures’ Inception 4
  • AstraZeneca and Innate Pharma announce global co-development and commercialisation collaboration for IPH2201 in immuno-oncologyAstraZeneca and Innate Pharma announce global co-development and commercialisation collaboration for IPH2201 in immuno-oncology
  • Microsoft Enables Epic Clients to Use Microsoft Azure Large Instances to Manage Large Epic EHR Database LoadsMicrosoft Enables Epic Clients to Use Microsoft Azure Large Instances to Manage Large Epic EHR Database Loads
  • FDA approves Karyopharm’s multiple myeloma drug for highly refractory patientsFDA approves Karyopharm’s multiple myeloma drug for highly refractory patients

Trending This Week

  • Novartis Drops Eye Disease Gene Therapy from $800M Gyroscope Acquisition
  • GSAC Engineering Acquires Key Intellectual Property and Assets from Duos Technologies GroupGelStat’s Subsidiary, GSAC Engineering, Launches Intelligent Correctional Facilities Automation Systems (iCAS) in the Industrial Security Market
  • Life Launches AI Clinical Trial Matching Assistant for Cancer
  • 79% of Healthcare Execs Believe Most Drug Diversion Goes Undetected
  • Moonshot Client Axolotl Announces Merger with Carmell Therapeutics, Elevating the Field of Regenerative Medicine
  • FDA Releases Updated Final Guidance for its Breakthrough Devices Program

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications